Effects of Fuscoporia obliqua on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients

Journal of Traditional Chinese Medicine

Volumn 28, Issue 1, 2008, Pages 49-57

  Maenaka, Toshihiro ^a   Oshima, Masami ^a   Itokawa, Yuka ^a   Masubuchi, Takashi ^a   Takagi, Yasuyuki ^a   Choi, Jung Sook ^b   Ishida, Torao ^a   Gu, Yeunhwa ^a  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b GyeongDo Provincial College   (South Korea)

Author keywords

Fuscoporia oblique; Glucose excursion and endothelial dysfunction; Insulin; Type 2 diabetic patients

Indexed keywords

ANTIDIABETIC AGENT; FUSCOPORIA OBLIQUA EXTRACT; GLUCOSE; INSULIN; LIPID; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARM BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIET THERAPY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; FEMALE; FUSCOPORIA OBLIQUA; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; MALE; MUSHROOM; NON INSULIN DEPENDENT DIABETES MELLITUS; PLETHYSMOGRAPHY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TEST MEAL;

EID: 41749125476     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(08)60014-x     Document Type: Article

References (21)

1. Coutinho M., Gerstein H.C., Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta regression analysis of published data from 20 studies of 95,783 individuals followed up for 12.4 years. Diabetes Care1999; 22 (2): 233-240,.
2. Yang K., Azoulay E., Attalah L., Zahar J.R., Van De Louw, A, Cerf C. Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation. Intensive Care Med 2003; 29 (3): 396-402.
3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso A Stop-Niddm Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA 2001; 290: 486-494.
4. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.
5. Verma S., Anderson T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002; 105: 546-549.
6. Verma S., Buchanan M.R., Anderson T.J., Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054-2059.
7. Nappo F., Esposito K., Cioffi M., Giugliano G., Molinari A.M., Paolisso G, Marfella R., Giugliano D., Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002; 39: 1145-1150.
8. McVeigh GE, Brennan GM, Johnstone GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. Impaired endothelium-dependent and independent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1902; 35: 771-776.
9. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004; 44: 2293-2300.
10. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005; 54: 1-7.
11. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-4641.
12. He J. Feng XZ, Lu Y, Zhao B. Three new triterpenoids from Fuscoporia obliqua. J Asian Nat Prod Res 2001: 3 (1): 55-61.
13. Zhang J. Wang G, Li H, Zhuang C, Mizuno T. Ito H. Mayuzuini H, Okamoto H, Li J. Antitumor active protein-containing glycans from the Chinese mushroom songshan lingzhi. Ganodermia tsugac inycelium. Biosci Biolechnol Biochem 1994: 58 (7): 1202-1205.
14. Shimabukuro M, Higa N, Takasu N, Tagawa T, Ueda S. A single dose of nateglinide improves postprandial endothelial dysfunction in type 2 diabetic patients. Diabet Med 2004. 21: 983-986.
15. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
16. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E. Evidence for an independent and cumulative effect of postprandial hypertrigly-ceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002; 106: 1211-1218.
17. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288: 2579-2588.
18. Yano M, Hasegawa G, Ishii M, Yamasaki M, Fukui M, Nakamura N, Yoshikawa T. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep 2004; 9: 111-116.
19. Vallejo S, Angulo J, Peiro C, Cercas E, Sanchez-Ferrer A, Nevado J, Llergo JL, Rodriguez-Manas L, Sanchez-Ferrer CF, Treatment with AB may improve endothelial dysfunction in streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol 2000; 36: 255-262.
20. Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I. Paroni R, Galluccio E, Pozza G, Chierchia S, Margonato A. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003; 107: 429-436.
21. Cardillo C. Campia U. Bryant MB. Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002: 106: 1783-1787.